These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 1740493)

  • 1. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.
    Hall JE; Schoenfeld DA; Martin KA; Crowley WF
    J Clin Endocrinol Metab; 1992 Mar; 74(3):600-7. PubMed ID: 1740493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
    Welt CK; Martin KA; Taylor AE; Lambert-Messerlian GM; Crowley WF; Smith JA; Schoenfeld DA; Hall JE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2645-52. PubMed ID: 9253348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
    Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal evaluation of the luteal phase and its transition into the follicular phase.
    Vermesh M; Kletzky OA
    J Clin Endocrinol Metab; 1987 Oct; 65(4):653-8. PubMed ID: 3116029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency.
    Adams JM; Taylor AE; Schoenfeld DA; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 1994 Sep; 79(3):858-64. PubMed ID: 7521353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal dynamics during luteal-follicular transition.
    Mais V; Cetel NS; Muse KN; Quigley ME; Reid RL; Yen SS
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1109-14. PubMed ID: 3106394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
    Gelety TJ; Pearlstone AC; Surrey ES
    Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
    Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone.
    McCartney CR; Gingrich MB; Hu Y; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2002 May; 87(5):2194-200. PubMed ID: 11994363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased follicular phase gonadotropin secretion is associated with impaired estradiol and progesterone secretion during the follicular and luteal phases in normally menstruating women.
    Schweiger U; Laessle RG; Tuschl RJ; Broocks A; Krusche T; Pirke KM
    J Clin Endocrinol Metab; 1989 May; 68(5):888-92. PubMed ID: 2497129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corpus luteum insufficiency induced by a rapid gonadotropin-releasing hormone-induced gonadotropin secretion pattern in the follicular phase.
    Soules MR; Clifton DK; Bremner WJ; Steiner RA
    J Clin Endocrinol Metab; 1987 Sep; 65(3):457-64. PubMed ID: 3114301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal programming: testosterone exposure of the female sheep during midgestation disrupts the dynamics of its adult gonadotropin secretion during the periovulatory period.
    Savabieasfahani M; Lee JS; Herkimer C; Sharma TP; Foster DL; Padmanabhan V
    Biol Reprod; 2005 Jan; 72(1):221-9. PubMed ID: 15355876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion.
    Reame N; Sauder SE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Aug; 59(2):328-37. PubMed ID: 6429184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiatergic influence on gonadotropin-releasing hormone and luteinizing hormone release during the macaque menstrual cycle.
    Pau KY; Berria M; Hess DL; Spies HG
    Biol Reprod; 1996 Aug; 55(2):478-84. PubMed ID: 8828858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition.
    le Nestour E; Marraoui J; Lahlou N; Roger M; de Ziegler D; Bouchard P
    J Clin Endocrinol Metab; 1993 Aug; 77(2):439-42. PubMed ID: 8345049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.